08:00 | Registration |
| Day One Session |
| Session Chair: Paul Collinson, Consultant Chemical Pathologist, St Georges University Hospitals NHS Foundation Trust, United Kingdom |
| |
09:00 | A Short History of Point of Care Testing: Using What We Know to Get to Precision Medicine Elizabeth Wagar, Professor, The University of Texas MD Anderson Cancer Center, United States of America
Point-of-care testing has transitioned from early easy-to-understand concepts to a more complicated paradigm. What has influenced this transition? A number of factors will be discussed including regulatory factors, the evolution of point-of-care technology, healthcare economics, and the development of cutting-edge personalized care. These factors challenge the point-of-care market. Discussion of these factors will be provided to assist in directing technology toward point-of-care utilization. |
09:30 | | Keynote Presentation Point-of-Care EFIRM-based Liquid Biopsy for Actionable EGFR Mutations in NSCLC David Wong, Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles, United States of America
EFIRM Liquid Biopsy (eLB) permits near perfect detection of circulating tumor DNA (ctDNA) as compared with tissue genotyping, using a drop of bodily fluid, direct detection, without processing with results available in 10 minutes, at the point-of-care. |
|
10:30 | Antibody Microarrays for Point of Care Detection from a Single Drop of Blood Ashutosh Chilkoti, Director, Duke University, United States of America
I will discuss a point-of-care diagnostic, the D4 Assay that we have developed, in which all reagents are printed and stored on a “non-fouling”protein and cell resistant polymer brush. |
11:00 | Coffee and Networking in Exhibition Hall |
11:30 | Bioanalytical surfaces for PoC applications Thomas Brandstetter, Group Leader, University of Freiburg, Germany
Point of Care diagnostics (PoCD) require rapid, simple, easy to handle and low-cost bioanalytical approaches. Bioanalytical surfaces play a key role for achieving diagnostic requirements. Here, we review the state of the art of bioanalytical surfaces for PoCD. |
12:00 | Paper Microfluidic Sensors for Point-of-care Diagnostic Applications in Low-resource Settings Elain Fu, Professor, Oregon State University, United States of America
This presentation will highlight the development of paper microfluidic tests for infectious disease diagnosis and therapy monitoring in low-resource settings. |
12:30 | Small Form Factor CMOS Based Sensors For Fast Detection Of Microorganisms And Bio Markers Valerio Pruneri, Group Leader, ICFO, Barcelona, Spain
|
13:00 | Lunch & Networking in Exhibition Hall |
14:30 | Technology Spotlight: Introducing micropoc®: High quality POC Results on Reader-less, Fully Disposable Systems Designed for Low Cost Manufacture Simon Forster, General Manager, Carclo Diagnostic Solutions
An overview of the exciting development of a group of unique POCT platforms that utilise novel microfluidics design, material science, precision manufacturing, micro-electronics and biochemistry, to provide high quality results on reader-less, fully disposable systems for a wide range of applications. |
14:45 | Particular Points of Care for External Quality Assessment Timothy Woods, Deputy Director, UK NEQAS for Blood Coagulation, United Kingdom
|
15:15 | Micro-Technologies as Enablers for Point-of-Care Applications Daniel Caminada, Section Head Microdiagnostics, Swiss Center for Electronics and Microtechnology, Switzerland
Next generation Point-of-Care devices are enabled by Micro-Technologies. CSEM SA is an applied research and technology organization with technology transfer to the industry in mind. Relevant in-house technology platforms for the diagnostic industry as well as the value of collaborations are highlighted. |
15:45 | Coffee and Networking in Exhibition Hall |
16:15 | The Accuracy of Point-of-care Glucose Testing and Its Impact on the Management of Critically Ill Patients Kathie Hermayer, Professor of Medcine, Medical University of South Carolina, United States of America Yusheng Zhu, Professor, Medical University of South Carolina, United States of America
This talk will recognize the pathophysiological changes of critically ill patients, review the limitations of the current point-of-care (POC) glucose meters and discuss the new FDA
guidelines and quality requirement for future POC glucose meters. |
17:15 | Drinks Reception |